The Impact of COVID-19 is included in Cold Chain Products for Plasma Fractionation Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Cold Chain Products For Plasma Fractionation Trends and Forecast
The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets. The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cold Chain Products For Plasma Fractionation by Segment
The study includes a forecast for the global cold chain products for plasma fractionation by type, end use, and region.
Cold Chain Products Market for Plasma Fractionation by Type [Shipment Analysis by Value from 2018 to 2030]:
• Ultra-low temperature freezer
• Plasma freezer
• Temperature monitoring devices
• Plasma contact shock freezer
• Blood transport boxes
• Ice-lined refrigerator
• Others
Cold Chain Products Market for Plasma Fractionation by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Blood collection centers and blood component providers
• Hospitals and transfusion centers
• Clinical research laboratories
• Others
Cold Chain Products Market for Plasma Fractionation by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Cold Chain Products Companies for Plasma Fractionation
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cold chain products companies for plasma fractionation cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cold chain products for plasma fractionation companies profiled in this report include-
• B Medical Systems
• Blue Star
• Thermo Fisher Scientific
• Godrej And Boyce
• Haier Biomedical
• Eppendorf
• Avantor
• Biolife Solutions
Cold Chain Products for Plasma Fractionation Market Insights
Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.
Blood collection center and blood component provider will remain the largest segment due to increasing number of diseases like hemophilia and immune deficiency disorders as well as liver diseases and rising aging population.
North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.
Features of the Global Cold Chain Products Market for Plasma Fractionation
Market Size Estimates: Cold chain products market for plasma fractionation size estimation in terms of value ($M).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cold chain products market for plasma fractionation size by type, end use, and region in terms of value ($M).
Regional Analysis: Cold chain products market for plasma fractionation breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the cold chain products market for plasma fractionation.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cold chain products market for plasma fractionation.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the cold chain products market for plasma fractionation size?
Answer: The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030.
Q.2 What is the growth forecast for cold chain products market for plasma fractionation?
Answer: The global cold chain products market for plasma fractionation is expected to grow with a CAGR of 4.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the cold chain products market for plasma fractionation?
Answer: The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.
Q4. What are the major segments for cold chain products market for plasma fractionation?
Answer: The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets.
Q5. Who are the key cold chain products market for plasma fractionation companies?
Answer: Some of the key cold chain products for plasma fractionation companies are as follows:
• B Medical systems
• Blue Star
• Thermo Fisher Scientific
• Godrej and Boyce
• Haier Biomedical
• Eppendorf
• Avantor
• Biolife Solutions
Q6. Which cold chain products market for plasma fractionation segment will be the largest in future?
Answer: Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.
Q7. In cold chain products market for plasma fractionation, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cold chain products market for plasma fractionation by type (ultra-low temperature freezer, plasma freezer, temperature monitoring devices,plasma contact shock freezer, blood transport boxes, ice-lined refrigerator, and others), end use (blood collection centers and blood component providers, hospitals and transfusion centers, clinical research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cold Chain Products For Plasma Fractionation Market, Cold Chain Products For Plasma Fractionation Market Size, Cold Chain Products For Plasma Fractionation Market Growth, Cold Chain Products For Plasma Fractionation Market Analysis, Cold Chain Products For Plasma Fractionation Market Report, Cold Chain Products For Plasma Fractionation Market Share, Cold Chain Products For Plasma Fractionation Market Trends, Cold Chain Products For Plasma Fractionation Market Forecast, Cold Chain Products For Plasma Fractionation Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Cold Chain Products Market for Plasma Fractionation: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cold Chain Products Market for Plasma Fractionation Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cold Chain Products Market for Plasma Fractionation by Type
3.3.1: Ultra-low Temperature Freezer
3.3.2: Plasma Freezer
3.3.3: Temperature Monitoring Devices
3.3.4: Plasma Contact Shock Freezer
3.3.5: Blood Transport Boxes
3.3.6: Ice-lined Refrigerator
3.3.7: Others
3.4: Global Cold Chain Products Market for Plasma Fractionation by End Use
3.4.1: Blood collection Centers and Blood Component Providers
3.4.2: Hospitals and Transfusion Centers
3.4.3: Clinical Research Laboratories
3.4.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Cold Chain Products Market for Plasma Fractionation by Region
4.2: North American Cold Chain Products Market for Plasma Fractionation
4.2.2: North American Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
4.3: European Cold Chain Products Market for Plasma Fractionation
4.3.1: European Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
4.3.2: European Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
4.4: APAC Cold Chain Products Market for Plasma Fractionation
4.4.1: APAC Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
4.4.2: APAC Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
4.5: ROW Cold Chain Products Market for Plasma Fractionation
4.5.1: ROW Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
4.5.2: ROW Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by Type
6.1.2: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by End Use
6.1.3: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by Region
6.2: Emerging Trends in the Global Cold Chain Products Market for Plasma Fractionation
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cold Chain Products Market for Plasma Fractionation
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cold Chain Products Market for Plasma Fractionation
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: B Medical systems
7.2: Blue Star
7.3: Thermo Fisher Scientific
7.4: Godrej and Boyce
7.5: Haier Biomedical
7.6: Eppendorf
7.7: Avantor
7.8: Biolife Solutions
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Cold Chain Products for Plasma Fractionation Market Report.